Voyxact
Payments companies reported to CMS as associated with Voyxact. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Voyxact, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Voyxact
These are the largest totals companies reported as associated with Voyxact. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Donald Molony | Houston, TX | Nephrology (Internal Medicine) | $7,181.95 |
| James Chevalier | New York, NY | Nephrology (Internal Medicine) | $6,802.31 |
| Osama Amro | Seattle, WA | Nephrology (Internal Medicine) | $6,658.60 |
| Nissreen Elfadawy | Chardon, OH | Nephrology (Internal Medicine) | $6,643.05 |
| James Tumlin | Lawrenceville, GA | Nephrology (Internal Medicine) | $2,920.00 |
| Anjay Rastogi | Los Angeles, CA | Nephrology (Internal Medicine) | $2,920.00 |
| Andrew Lazar | Beachwood, OH | Nephrology (Internal Medicine) | $2,644.43 |
| Luis Velez | San Antonio, TX | Nephrology (Internal Medicine) | $1,971.27 |
| Anthony Chang | Burr Ridge, IL | Anatomic Pathology & Clinical Pathology | $283.77 |
| Niloofar Nobakht | Los Angeles, CA | Nephrology (Internal Medicine) | $165.41 |
Prescribed Voyxact?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.